Presentation THT Abstracts 2025 Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs February 11, 2025
Presentation THT Abstracts 2025 Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database Presenter: Thitiphan Srikulmontri February 11, 2025
Presentation THT Abstracts 2025 Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction Presenter: Emmanuel Otabor February 11, 2025
Presentation THT Abstracts 2024 Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics Presenter: Nadira Hamid March 04, 2024
Presentation THT Abstracts 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF Presenter: Sheldon Litwin March 04, 2024
Presentation THT Abstracts 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis † Presenter: Marat Fudim March 04, 2024